stockrowIngevity Corporation
NGVT Basic Materials Specialty Chemicals
Ingevity Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, down 2.71% from fiscal 2024.
- Revenue
- −5.25%
- EPS
- +125.4%
- Free cash flow
- −136.1%
- Total debt
- −14.5%
Quarter to June 2026, against a year earlier
Follow NGVT
Alert me
Ingevity Corporation (NGVT) Net income
Ingevity Corporation's net income for fiscal 2025 was −$167.1M, compared with −$430.3M in fiscal 2024. Over the twelve months to 30 June 2026 it was $54.0M. Over the past ten years it has ranged from −$430.3M (fiscal 2024) to $211.6M (fiscal 2022); the current reading is higher than 18% of that period. Ingevity Corporation ranks 28th of 60 Specialty Chemicals companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | −$167.1M | — |
| FY2024 | −$430.3M | — |
| FY2023 | −$5.4M | — |
| FY2022 | $211.6M | 79.17% |
| FY2021 | $118.1M | (34.90%) |
| FY2020 | $181.4M | (1.25%) |
| FY2019 | $183.7M | 1.05% |
| FY2018 | $181.8M | 25.21% |
| FY2017 | $145.2M | 227.03% |
| FY2016 | $44.4M | (47.33%) |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Jun 2026 | $35.3M | (40.97%) |
| Mar 2026 | $59.8M | — |
| Dec 2025 | −$84.6M | — |
| Sep 2025 | $43.5M | — |
| 42 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| FUL H. B. Fuller Company compare | $197.8M |
| IOSP Innospec Inc. compare | $141.0M |
| KWR Quaker Houghton compare | $97.3M |
| HWKN Hawkins, Inc. compare | $85.8M |
| WDFC WD-40 Company compare | $82.3M |
| NGVT Ingevity Corporation | $54.0M |
| MTX Minerals Technologies Inc. compare | −$63.0M |
| CC The Chemours Company compare | −$154.0M |
| STDN Standard Nuclear Inc compare | — |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on NGVT
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement